Purchases and Sales Made in Q4 2024 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q4 2024. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
14.4KNew |
$16.3K - $29.2K
|
14.4K
$18.1K
|
|
|
Jan 22, 2025
Q4 2024
|
Wetzel Investment Advisors, Inc.
Indianapolis, IN |
BUY
|
- |
10KNew |
$11.3K - $20.2K
|
10K
$12.5K
|
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
9.71K+ 63.76% |
$11K - $19.6K
|
24.9K
$31.2K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
5.1KNew |
$5.76K - $10.3K
|
5.1K
$6.37K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
100New |
$113 - $202
|
100
$125
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-340- 1.28% |
$384 - $687
|
26.2K
$32.7K
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-340- 0.16% |
$384 - $687
|
213K
$266K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-1.8K- 78.8% |
$2.04K - $3.64K
|
485
$606
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-3.77K- 13.65% |
$4.25K - $7.61K
|
23.8K
$29.8K
|
|
|
Feb 05, 2025
Q4 2024
|
Yelin Lapidot Holdings Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-65.6K- 8.1% |
$74.1K - $132K
|
744K
$930K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-298K- 74.05% |
$337K - $602K
|
104K
$131K
|